In this study, we show for the first time that inhibition of c-Met by Ad-mediated shRNA (dl/shMet4, dl/shMet5, and dl/shMet4+5) expression results in robust anti-tumor efficacy via autophagic cell death in various cancer cells. Here, MET is linked to cancer.